WEBTOON Entertainment Inc., a leading global entertainment company known for its mobile webcomic platforms, announced it will report its third quarter 2026 financial results on November 9, 2026, after market close. The company's management will host a conference call at 4:30 p.m. ET to discuss the results, which will be available via live webcast and archived online for one year. This update is important for investors tracking the company's performance and growth in the digital storytelling and entertainment sector.
WEBTOON Entertainment Inc. will report its third quarter 2026 financial results on November 9, 2026. For readers following the media sector, here is Pluang's market snapshot as of Oct 20, 2026 01:02 WIB: out of 58 priced US media stocks tradable on Pluang, 22 rose and 34 fell today. Notable movers include BCE Inc. Common Stock at USD 19.96 with a -1.82% change, TKO Group Holdings Inc at USD 172.69 with a -1.60% change, and EchoStar Corporation Common Stock at USD 86.71 with a +1.57% change. Typical hold times on Pluang range from 5 to 32 days among these stocks.
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
